Ambulatory cardiac monitoring
Philips helps to extend patient oversight beyond hospital walls and improve outcomes with a cardiac ambulatory monitoring portfolio that includes a range of monitors with flexible wear options to enhance patient compliance. Cloud-based AI and advanced algorithms quickly process high-quality ECG data into actionable reports that integrate with EMR to accelerate decision-making, support streamlined workflow, and enable patient-centered care. Philips Mobile Cardiac Telemetry – MCOT detects atrial fibrillation (AF) with proven 100% sensitivity and 100% positive predictability in the detection of ≥30-second AF episodes . Its use for 30-day continuous monitoring of post-cryptogenic stroke patients prior to fitting them with an implantable loop recorder (ILR) resulted in almost eight times lower costs, minimizing the total cost per patient with detected AF by US$ 198,909 compared to monitoring with ILR only .
To connect with experts and learn more about Philips cardiology solutions, stop by Philips booth #338. The clinical study presentation by Dr. Mohamad Alkhouli will take place on March 4, 2023, 1:45 PM - 1:55 PM (CST) and the presentation by Dr. Sean Pokorney on March 6, 2023, 9:45 AM - 10:30 AM (CST). The presentation by Dr. Eric Secemsky is in digital-only format and can be accessed through the ACC.23/WCC eAbstracts site by registered users.
 Based on MIT-BIH (Massachusetts Institute of Technology-Beth Israel Hospital) Arrhythmia Database testing of ≥30-second AF episodes. (FDA 510k submission)
 Difference in cost per patient with detected AF monitored with ILR ($228,507) minus cost per patient with detected AF patients using the MCOT patch ($29,598). Medic G, Kotsopoulos N, Connolly MP, Lavelle J, Norlock V, Wadhwa M, Mohr BA, Derkac WM. Mobile Cardiac Outpatient Telemetry Patch vs Implantable Loop Recorder in Cryptogenic Stroke Patients in the US - Cost-Minimization Model. Med Devices (Auckl). 2021 Dec 18;14:445-458. doi: 10.2147/MDER.S337142. PMID: 34955658; PMCID: PMC8694406.
 Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129.
 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96.